Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 4

Next generation M&S packages deployable and accessible for MIDD and Model Integrated Evidence - Advances Through GDUFA-Sponsored Research

Development of A User-Friendly Platform for Model-Integrated Bioequivalence Analysis

Tuesday, November 12, 2024
2:30 PM – 3:00 PM MST
Location: Sonoran Sky Ballroom 5 - 8

    Speaker(s)

  • Andrew C. Hooker, PhD, ISOP member

    Professor of Pharmacometrics
    Uppsala University
    Uppsala, Sweden

    Disclosure(s): Pharmetheus AB: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):
Andrew C. Hooker, PhD, ISOP member: Pharmetheus AB: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)